Maine has passed LD 675, An Act To Increase Prescription Drug Pricing Transparency. This Act requires pharmacy benefit managers (PBMs) and other drug supply chain entities to disclose certain drug pricing information to the state in order to increase pricing transparency and regulation.

LD 1450 has been enacted into law without action from the Governor. This Act To Provide Fairness in Communications from Pharmacy Benefits Managers prohibits a pharmacy benefit manager (PBM) from using untrue, deceptive, or misleading advertising practices in order to trick or misguide patients or other entities.

Maine Governor Janet Mills has enacted LD 603, a new law that amends the Maine Pharmacy Act to officially recognize pharmacists as providers of health care services. The situation during the pandemic has highlighted what was already true - that pharmacists are significantly valuable to patient health beyond dispensing. This new law will hopefully lead to more opportunities for pharmacists to expand their scope of practice.